SAN FRANCISCO and NESS ZIONA, ISRAEL, Sept. 19, 2019 /PRNewswire-PRWeb/ — Medrio, a leading provider of eClinical technology for pharma, medical device, and diagnostic companies conducting clinical trials, and Bioforum, a data-focused contract research organization (CRO) offering end-to-end services to life sciences companies worldwide, today announced a partnership to optimize the clinical data standardization process. The collaboration will provide Medrio clients with access to JET-Convert™, Bioforum’s industry-leading solution for standardizing clinical data in a regulatory compliant, submission-ready format, furthering efforts to accelerate clinical trial timelines while improving patient safety and outcomes.

JET-Convert™ streamlines the flow of research data from collection through submission, enabling the creation of an integrated clinical database that is easily searchable and, thus, can help speed up decision-making processes. Leveraging artificial intelligence (AI) technology, Bioforum’s pioneering solution automates clinical data standardization using a submission-ready format that follows Clinical Data Interchange Standards Consortium (CDISC) guidelines. Required by the FDA, CDISC standards address the need to better structure and improve the quality and consistency of research data, allowing for the meaningful exchange of information between all clinical trial stakeholders, including clinicians, researchers, pharmaceutical companies and regulatory authorities.

“Reducing variation and standardizing clinical data is central to improving its quality and usability,” said Mike Novotny, Founder and Chief Executive Officer of Medrio. “We’re thrilled to partner with Bioforum and provide our clients with access to its pioneering JET-Convert solution, a powerful tool that will enable better data integration and reusability, the facilitation of data exchange with partners as well as regulatory reviews and audits, and, ultimately, speed up efforts to bring innovative medical treatments to patients around the world.”

Bioforum’s Co-Founder and President Amir Malka added: “Our partnership with Medrio addresses the industry’s urgent need for a solution that can standardize clinical data at scale. We’re excited to launch this collaboration and confident that together we can help our life sciences clients improve efficiencies in all stages of clinical development — from study design and start-up through execution and submission.”

About Medrio
Medrio offers software based eClinical solutions, providing clinical researchers with the tools necessary to accelerate research, eliminate hurdles, and maximize return on investment. Partnering with sponsors and CROs across all phases of research in pharma, biotech, medical device, and diagnostics, Medrio supports its clients along their journey to medical discovery.

Medrio website: medrio.com

For more information, please contact:
Lewis Baird, Senior Director, European Business Development
MEDRIO eClinical
+421 907 879 799
lbaird@medrio.com

About Bioforum    
Bioforum is a data focused CRO, offering a wide range of consulting services, medical writing, data management and bio-statistical support. With multi-disciplinary teams with clinical backgrounds, Bioforum’s experts help clients comprehend the value of their clinical data simply by making it readily available for monitoring, analysis and ready for submission. Bioforum partners with its clients to boost and improve the utilization of their clinical data and guarantee its integrity and accuracy.

Bioforum website: http://www.bioforumgroup.com

For more information, please contact:
Tali Rahinstein, VP Business Development
Bioforum Ltd.
+972-8-3730500, ext.553
talir@bioforum.co.il

SOURCE Medrio, Inc.